Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pascal Soriot
Pharma
AZ, Daiichi's Enhertu turned away by NICE on pricing grounds
After a prior skirmish over tax policy in England, AstraZeneca is now butting heads with officials in the country over innovative drug access.
Eric Sagonowsky
Jul 29, 2024 9:16am
The top 10 best-paid CEOs in Big Pharma in 2023
Jun 17, 2024 3:00am
AZ plans to launch 20 new drugs, achieve $80B in revenue by 2030
May 21, 2024 10:09am
Is AstraZeneca stretching too thin with M&As? CEO says 'no'
Apr 25, 2024 11:09am
AZ's pay proposal for Pascal Soriot passes at investor meeting
Apr 12, 2024 9:40am
AZ's CEO pay debate heats up ahead of shareholder meeting
Apr 10, 2024 1:04pm
